IMA vs MTCH · rev $9.2M vs P/E 13, rev $3.48B
ImageneBio, Inc. (IMA) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
IMA currently screens at market cap $64.7M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the IMA and MTCH stock pages for the full models.
Not investment advice.